Holen Sie sich die Stockscreener-App
3.97
4.11%
-0.17
Handel nachbörslich:
3.97
Schlusskurs vom Vortag:
$4.14
Offen:
$4
24-Stunden-Volumen:
190.25K
Relative Volume:
1.14
Marktkapitalisierung:
$130.68M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-12.48M
KGV:
-10.18
EPS:
-0.39
Netto-Cashflow:
$-7.93M
1W Leistung:
-6.37%
1M Leistung:
+21.41%
6M Leistung:
+42.81%
1J Leistung:
+15.07%
1-Tages-Spanne:
$3.85
$4.17
1-Wochen-Bereich:
$3.83
$4.28
52-Wochen-Spanne:
$2.07
$4.98
Anixa Biosciences Inc Stock (ANIX) Company Profile
Firmenname
Anixa Biosciences Inc
Sektor
Branche
Telefon
408-708-9808
Adresse
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE
Vergleichen Sie ANIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANIX
Anixa Biosciences Inc
|
3.97 | 136.28M | 0 | -12.48M | -7.93M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Anixa Biosciences Inc Stock (ANIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-21 | Eingeleitet | Maxim Group | Buy |
| 2022-12-23 | Eingeleitet | Chardan Capital Markets | Buy |
| 2021-04-12 | Eingeleitet | H.C. Wainwright | Buy |
Anixa Biosciences Inc Aktie (ANIX) Neueste Nachrichten
What momentum indicators show for Anixa Biosciences Inc. stockQuarterly Investment Review & High Conviction Investment Ideas - newser.com
Mission Wealth Management LP Sells 100,000 Shares of Anixa Biosciences Inc $ANIX - MarketBeat
Will Anixa Biosciences Inc. stock benefit from commodity prices2025 Momentum Check & Risk Controlled Stock Pick Alerts - newser.com
Anixa Biosciences Inc. stock prediction for this weekTrade Ideas & AI Powered Market Entry Ideas - newser.com
How Anixa Biosciences Inc. stock reacts to oil pricesJuly 2025 PostEarnings & Technical Pattern Alert System - newser.com
How to build a dashboard for Anixa Biosciences Inc. stock2025 Short Interest & Accurate Technical Buy Alerts - newser.com
Is Anixa Biosciences Inc. stock a contrarian buyMarket Weekly Review & Low Drawdown Trading Techniques - newser.com
Backtesting results for Anixa Biosciences Inc. trading strategiesWall Street Watch & Daily Stock Trend Watchlist - newser.com
Is Anixa Biosciences Inc. trending in predictive chart modelsPortfolio Performance Report & Consistent Return Investment Signals - newser.com
Is Anixa Biosciences Inc. stock supported by strong cash flowsJuly 2025 Trends & Technical Analysis for Trade Confirmation - newser.com
Will Anixa Biosciences Inc. stock maintain growth storyJuly 2025 Trends & Precise Swing Trade Entry Alerts - newser.com
Is Anixa Biosciences Inc. (CY71) stock nearing a technical breakoutPortfolio Return Summary & Weekly Momentum Picks - newser.com
How supply chain issues affect Anixa Biosciences Inc. stock2025 Price Momentum & Verified Swing Trading Watchlists - newser.com
How Anixa Biosciences Inc. (CY71) stock reacts to fiscal policies2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - newser.com
Is Anixa Biosciences Inc. (CY71) stock a safe buy pre earnings2025 Trade Ideas & Fast Gain Stock Tips - newser.com
Intraday pattern recognizer results for Anixa Biosciences Inc.Earnings Risk Report & Verified Trade Idea Suggestions - newser.com
Key metrics from Anixa Biosciences Inc.’s quarterly dataPortfolio Gains Report & Real-Time Volume Spike Alerts - newser.com
Will Anixa Biosciences Inc. stock outperform tech sector in 2025Weekly Loss Report & Risk Adjusted Swing Trade Ideas - newser.com
Developing predictive dashboards with Anixa Biosciences Inc. dataBull Run & Weekly High Momentum Picks - newser.com
Using data filters to optimize entry into Anixa Biosciences Inc.2025 Market WrapUp & Long-Term Capital Growth Strategies - newser.com
Anixa Biosciences, Inc. (ANIX) Analyst insights, Price targets and Recommendations - Yahoo! Finance Australia
Finanzdaten der Anixa Biosciences Inc-Aktie (ANIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):